Know Cancer

forgot password

Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

18 Years
46 Years
Not Enrolling
Polycystic Ovary Syndrome

Thank you

Trial Information

Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive
age women, affecting an estimated 9-18% of all women in this age group. To diagnose of PCOS
in early life is especially important because it is now thought to increase metabolic and
cardiovascular risks. Investigating PCOS is crucial as it is now considered to increase
metabolic and cardiovascular risk, thereby impacting the health of women to a much greater
extent than previously thought. We are plan using retrospective analysis to evaluate the
clinical and biochemical presentation of PCOS in different aged groups.

Inclusion Criteria:

- Reproductive age women with sufficient data

Exclusion Criteria:

- Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal
anomalies (e.g. Turner syndrome)

- women who had had menarche at less than 3 years of age, Day 3 FSH > 15, or who were
older than 46

- women with inadequate clinical/biochemical records

- and women who had had ovarian cysts or ovarian tumors in ultrasonography examination

- pregnancy women

Type of Study:


Study Design:

Time Perspective: Retrospective

Principal Investigator

Ming-I Hsu

Investigator Role:

Principal Investigator

Investigator Affiliation:

Taipei Medical University WanFang Hospital


Taiwan: Department of Health

Study ID:




Start Date:

February 2011

Completion Date:

April 2012

Related Keywords:

  • Polycystic Ovary Syndrome
  • Polycystic ovarian syndrome (PCOS)
  • Polycystic Ovary Syndrome